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Abstract: Macrosphyra longistyla has been used in many traditional systems of medicine for its
anti-hemorrhagic, antidiabetic, anti-ulcer, and anti-diarrhea properties. The acetylcholinesterase
(AChE) and butyrylcholinesterase (BuChE) inhibitions of the crude methanol extracts and its various
partitioned fractions were determined by a modified method of Ellman. An evaluation of the
antioxidant activity was carried out using 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging,
ferric reducing power, and nitric oxide scavenging assays. The total flavonoids were estimated based
on the aluminum chloride method, while the total tannins and phenolics were estimated based
on the vanillin–HCl and Folin–Ciocalteu method, respectively. The ethyl acetate fraction had the
highest DPPH radical scavenging activity, and the highest ferric reducing power with a concentration
providing 50% inhibition (IC50) of 0.079 mg/mL and 0.078 mg/mL, respectively, while the crude
methanol extract had the highest nitric oxide scavenging activity with an IC50 of 0.008 mg/mL. The
methanol extract had the highest phenolics and flavonoids contents, while the aqueous fraction had
the highest tannin content. The crude methanol extract had the best AChE and BuChE inhibitory
action, with an IC50 of 0.556 µg/mL and 5.541 µg/mL, respectively, suggesting that the plant had a
better AChE inhibiting potential. A moderate correlation was observed between the phenolic content
and DPPH radical scavenging, NO radical scavenging, and AChE inhibitory activities (r2 = 0.439,
0.430, and 0.439, respectively), while a high correlation was seen between the flavonoid content
and these activities (r2 = 0.695, 0.724, and 0.730, respectively), and the ferric reducing antioxidant
power correlated highly with the proautocyanidin content (r2 = 0.801). Gas chromatography mass
spectrometry (GCMS) revealed decanoic acid methyl ester (24.303%), 11,14-eicosadienoic acid methyl
ester (16.788%), linoelaidic acid (10.444%), pentadecanoic acid (9.300%), and 2-methyl-hexadecanal
(9.285%). Therefore, we suggest that M. longistyla contain bioactive chemicals, and could be a good
alternative for the management of Alzheimer’s and other neurodegenerative diseases.
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1. Introduction
Alzheimer’s disease and other neurodegenerative conditions are usually characterized by the
slow, but progressive, dysfunction and loss of neurons in the central nervous system [1]. About
55 million people are suffering from one form of neurodegenerative disease (ND) or another, with
an expected rise in this figure the with increasing age of the population [2,3]. Despite the volume
of research on the pathogenesis of neurodegenerative conditions, appropriate treatment is yet to be
found [4]. However, several factors, including aging [5] and some pathological conditions, such
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as impaired mitochondrial function [6], aggregated proteins deposit [7], neuroinflammation [8],
cholinergic deficit [9], and oxidative stress [10], have been associated with NDs. Thus, the management
of NDs involves addressing one or more of the associated conditions. The currently available therapies
for Alzheimer’s disease (AD) are cholinesterase inhibitors such as rivastigmine and donepezil, which
only reduce disease progression and provide symptomatic relieve [11]. Thus, efforts are still being
made to find alternative and better therapeutic options.
Macrosphyra longistyla is a shrub found in several tropical countries. It has long, arching stems that
are about 4 m long [12]. M. longistyla has been used traditionally as an antihemorrhagic in Benin [13],
as an antidiabetic in Nigeria and Côte d’Ivoire [14,15], as a contraceptive and for the restoration of
fertility [16], for ulcers [17], and for diarrhea [18]. Fresh wildly-collected leaves are eaten as a vegetable
by the Gourmantché, Aïzo, and Cotafon people in Benin [19]. It is also widely consumed in Togo [20].
The leaves have been suggested an indigenous food ingredient for complementary food formulations to
combat infant malnutrition [21]. To the best of our knowledge, the chemical constituents and biological
activity of this plant have not been reported in the literature. This study therefore investigates its
anticholinesterase and anti-oxidant potentials, as well as phytochemical characterization.
2. Materials and Methods
2.1. Plant Material
The leaves of Macrosphyra longistyla were collected from Agbogi village in Osun State in December
2017. The plant was identified and authenticated by Mr. Odewo of the Forest Herbarium Ibadan (FHI),
with voucher number FHI 112042. The voucher specimen were deposited at the herbarium of the
Department of Pharmacognosy, University of Ibadan.
2.2. Plant Extraction and Partitioning
The leaves were air-dried and pulverized. About 2.25 kg of the powdered leaf was macerated
using 100% methanol. The extract was filtrated using a Buchner funnel, and concentrated in vacuo
so as to obtain a crude methanol extract. Then, 80 g of the crude methanol extract was partitioned
into n-hexane, ethyl acetate, and water, to obtain the respective fractions, which were concentrated in
vacuo and used for the subsequent experiments. The percentage yield of both extract and fractions
were determined.
2.3. Phytochemical Screening
The preliminary phytochemical screening of the crude methanol extract was carried out using
standard procedures. These include tests for alkaloids using Dragendorff and Wagner reagents, the
Borntrager’s test for anthraquinones, and a ferric chloride test for phenolic compounds [22,23].
2.4. Determination of the Total Phenol Content (TPC)
The total phenol content in the methanolic extract and various fractions of M. longistyla were
determined based on a previously described procedure [24]. Then, 2.5 mL of 10% Folin–Ciocalteau’s
reagent was mixed with 2 mL of 2% sodium carbonate solution (Na2CO3), followed by the addition of
0.5 mL of methanolic extract and fractions of M. longistyla (1 mg/mL). The mixture was incubated at
45 ◦C for 15 min, and absorbance was taken at 765 nm. The quantification was done with respect to
the standard of gallic acid at different concentrations (1, 0.5, 0.25, 0.125, 0.063, and 0.031 mg/mL). The
content of the total phenolic compounds was calculated based on a standard curve prepared using
gallic acid and expressed as milligrams of gallic acid equivalent (GAE) per gram of sample.
2.5. Determination of Total Flavonoid Contents (TFC)
The total flavonoid content was determined using the aluminum chloride colorimetric method [25].
In this method, 1 mL of crude extract or fractions of M. longistyla were mixed with 3 mL of methanol,
Antioxidants 2019, 8, 400 3 of 15
followed by 0.2 mL of 10% aluminum chloride (AlCl3), 0.2 mL of potassium acetate (1 M), and
5.6 mL of distilled water, and left at room temperature for 30 min. Absorbance was taken at 420 nm.
Quantification was done with respect to the standard of gallic acid at different concentrations (1, 0.5,
0.25, 0.125, 0.063, and 0.031 mg/mL). The total phenolic content was calculated based on a standard
curve prepared using gallic acid, and expressed as milligrams of gallic acid equivalent (GAE) per gram
of sample.
2.6. Determination of Pro-Anthocyanidin Content (PAC)
The vanillin–HCl method was used for the quantitative determination of condensed tannins
(proanthocyanidins) [26]. In this method, 3 mL of 4% vanillin in methanol, and 1.5 mL of hydrochloric
acid (HCl) was added to 0.5 mL of extract/fractions (1 mg/mL). The mixture was vortexed thoroughly
and allowed to stand for 15 min at room temperature. Absorbance was read at 500 nm. A calibration
curve was prepared using a standard gallic acid solution. All of the results were expressed as mg gallic
acid equivalents (GAE) per gram of sample.
2.7. DPPH (2,2-Diphenyl-1-Picrylhydrazyl Hydrate) Radical Scavenging Assay
The radical scavenging ability of the fractions was determined using the stable radical DPPH
(2,2-diphenyl-1-picrylhydrazyl hydrate), as previously described [27]. In this assay, 1 ml of 0.1 mM
DPPH was mixed with 1 mL of crude extract and fractions of M. longistyla at different concentrations
(1, 0.5, 0.25, 0.125, 0.063, and 0.031 mg/mL), as well as the positive controls (ascorbic acid and
2,6-di-tert-butyl-4-methylphenol (DDM)) at different concentrations (1, 0.5, 0.25, and 0.125 mg/mL). The
reaction was vortexed and left in the dark at room temperature for 30 min, after which the absorbance
was taken at 517 nm. The percentage inhibition was calculated as follows:
I% = [(Ablank − Asample)/Ablank] × 100
where Ablank is the absorbance of the control reaction (containing all reagents except the test compound),
and Asample is the absorbance of the test compound. The sample concentration providing 50% inhibition
(IC50) was also calculated.
2.8. Nitric Oxide (NO) Scavenging Assay
The nitric oxide scavenging assay was carried out as previously described [28]. First, 2 mL of
sodium nitroprusside was mixed with 0.5 mL of phosphate buffer pH 7.4 and 0.5 mL of different
concentrations of extract (0.0031–1.0 mg/mL). The mixture was incubated at 25 ◦C for 150 min, and an
initial absorbance (A0) was taken at 540 nm. Thereafter, 0.5 mL of the incubated mixture was mixed
with 1 mL of a sulfanilic acid reagent and 1 mL of naphthylethylenediamine dichloride (0.1% w/v), and
incubated at room temperature for 30 min, before another absorbance (A1) was taken at 540 nm. The
same reaction mixture without the extract but with the equivalent amount of methanol served as the
negative control. Ascorbic acid and DDM at various concentrations were used as the standard. All of
the experiments were in triplicates. The percentage nitrite radical scavenging activity of the extracts
and standard were calculated using the following formula:
% inhibition of NO = [A0 − A1]/A0 × 100
where A0 is the absorbance before the reaction, and A1 is the absorbance after the reaction.
2.9. Ferric Reducing Antioxidant Assay
The reducing power was determined according to the method of Oyaizu [29]. Substances with a
reducing ability react with potassium ferricyanide (Fe3+) to form potassium ferrocyanide (Fe2+), which
then reacts with ferric chloride to form a ferric ferrous complex that has an absorption maximum at
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700 nm. Briefly, 0.2 mL of various concentrations of plant extract and fractions was mixed with 0.2 mL
of phosphate buffer and 0.2 mL of potassium ferricyanide. The mixture was vortexed and incubated
at 50 ◦C for 20 min. After cooling, 0.2 mL of 10% trichloroacetic acid (TCA) was then added to the
mixture and centrifuged at 4500 rpm for 10 min. Then, 100 µL of the upper solution was mixed with
20 µL of the ferric chloride solution and 100 µL of distilled water. The absorbance was taken at 700 nm.
The control was prepared in a similar manner, but without the test sample. Ascorbic acid and DDM at
various concentrations were used as the standard. The experiments were done in triplicates.
2.10. Cholinesterase Inhibitory Assay
Acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitions were determined
spectrophotometrically using acetylcholine iodide and butrrylcholine iodide as substrates, respectively,
by a modified method of Ellman [30]. The serial dilutions of the fractions were subjected to this
test using eserin and donepezil as the positive control. Then, 5 mg of both the extract and fractions
were dissolved in 1 mL of methanol. Serial dilutions of each sample were done in order to obtain
the final concentrations of 1, 0.5, 0.25, 0.125, and 0.0625 mg/mL, while the positive controls (eserin
and donepezil) were also diluted serially to obtain the final concentrations of 0.1, 0.05, 0.025, 0.0125,
0.00625, and 0.003125 mg/mL. Thereafter, 20 µL of each concentration was pipetted into the micro
plates, followed by 240 µL of the phosphate buffer (pH 8) and 20 µL of the enzyme, which was then
vortexed. The plates were then incubated at 37 ºC for 30 min. After incubation, 20 µL of 25 mM of
the substrate (acetylthiocholinecholine iodide (ATChI) or butyrylthiocholine chloride (BTChCl)) was
added to the reaction mixture, followed by the addition of 20 µL of 10 mM 5, 5′-Dithiobis-2-nitrobenzoic
acid (DTNB). The hydrolysis of acetylcholine iodide or butryrylthiocholine chloride was determined
spectrophotometrically at 412 nm. The assay was carried out in triplicates, with methanol as the
negative control. The percentage inhibition was computed using the following formula:
∆a− ∆b
∆a
× 100
where ∆a is the change in absorbance of the negative control, and ∆b is the change in absorbance of
the sample.
2.11. Gas Chromatography Mass Spectrometry (GCMS) Analysis
One microliter (1 µL) of the sample diluted in hexane was analyzed on a Bruker 450 gas
chromatography-300 mass spectrometer (GCMS) system operating in EI mode at 70 eV, equipped
with a HP-5 MS fused silica capillary system with a 5% phenylmethylsiloxane stationary phase. The
capillary column parameter was 30 m by 0.25 mm, while the film thickness was 0.25 µm. The initial
temperature of the column was set at 70 ◦C, and heated to 240 ◦C at a rate of 5 ◦C/min, with the final
temperature kept at 450 ◦C. The run time was 66.67 min, and helium was used as the carrier gas at a
flow rate of 1 min/min. The split ratio was 100:1. The scan time was 78 min, with a scanning range of
35 to 450 amu.
2.12. Statistical Analysis
All of the data were analyzed using GraphPad Prism 6.0, and were expressed as mean ± standard
error of the mean (SEM). The correlation and regression analysis of the activities (Y) versus the total
phytochemical content (X) were carried out using the online Quest Graph™ Linear, Logarithmic,
Semi-Log Regression Calculator [31].
3. Results and Discussion
M. longistyla has been reportedly used for managing different ailments in traditional medicine
[13–18]. In an ethnomedical survey carried out by us, the plant was mentioned as a memory enhancer.
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Thus, the present study was carried out to investigate its phytochemical content, as well as evaluate
the antioxidant and cholinesterase inhibitory activities of the extracts and partitioned fractions.
The preliminary phytochemical screening of the methanol extract revealed the presence of tannins,
flavonoids, phenolics, terpenoids, and saponins. Anthraquinones and alkaloids were, however, found
absent in the plant (Table 1).
Table 1. Phytochemical screening results of Macrosphyra longistyla.
Tests Observations Inferences
1. Alkaloids
a. Dragendorff Deep yellow color Alkaloid absent
b. Wagner test Orange color Alkaloid absent
2. Anthraquinones
a. Borntrager’s test Milky color Anthraquinone absent
3. Flavonoids Yellow coloration Flavonoids present
4. Phenols Dark coloration Phenols present
5. Tannins Blue black coloration Tannin present
6. Saponin Frothing which disappear after sometime Saponin present
7. Terpenoid Dark green coloration Terpenoids present
The percentage yield of the extract and fractions (expressed as weight of extract/fraction relative
to the weight of the initial plant material) ranged from 4.70% to 40.00%, with the highest being the
aqueous fraction (Table 2). This suggests that the polar solvent was able to extract more constituents,
probably because of the solubility of the polar compounds present in the plant material.
Table 2. The total phenolics, flavonoids, and authocyanidins content in the extract and fractions of
M. longistyla.
Assays ME HF EF AF
% Yield 6.18 4.70 7.11 40.00
Total phenolics (mg GAE/g) 18.30 ± 0.04 7.56 ± 0.12 16.06 ± 0.13 9.02 ± 0.02
Total flavonoids (mg GAE/g) 16. 07 ± 0.14 5.02 ± 0.01 10.49 ± 0.014 11.62 ± 0.01
Total tannins (mg GAE/g) 24. 44 ± 0.32 2.99 ± 0.06 9.12 ± 0.17 26.11 ± 0.02
Data are expressed as mean ± standard error of the mean (SEM; n = 3). GAE—gallic acid equivalent; ME—methanol
extract; HF—hexane fraction; EF—ethyl acetate fraction; AF—aqueous fraction.
Furthermore, the content of the phenols (TPC), flavonoids (TFC), and the tannins (PAC) was
estimated quantitatively. The TPC, as determined by the Folin–Ciocalteu method, ranged from
7.56 ± 0.12 to 18.30 ± 0.04 mg GAE/g of extract (Table 2). Both the crude extract and the various
fractions had an appreciable total phenolic content, with the methanol extract and the ethyl acetate
fractions having the highest TPC, while the n-hexane fraction had the least TPC. The total flavonoid
and proauthocyanidin contents, also reported as mg GAE/g of extract, showed that the TFC ranged
from 5.02 ± 0.01 to 16. 07 ± 0.14 mg GAE/g of extract, while the PAC ranged from 2.99 ± 0.06 to
26.11 ± 0.02. In both cases, the hexane fraction had the least amount (Table 2).
Phenolic compounds are present in plant tissues and serve as antioxidants [32], because of the
presence of hydroxyl groups, which are responsible for their scavenging ability. Thus, they are capable
of reacting with active oxygen radicals such as hydroxyl radicals [33]. Flavonoids are polyphenolic
compounds, and are responsible for some of the health benefits of vegetable and fruits [34]. They are
known to play an active role in the quenching of free radicals, because of their redox properties [35].
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Tannins, however, are a high molecular weight polyphenolic that have also been implicated as
antioxidants [36].
The antioxidant activity of the extract and fractions was evaluated by the DPPH and NO radical
scavenging activity, as well as the ferric reducing power, while the AChE inhibitory activity was
evaluated by Ellman’s colorimetric assay.
DPPH is usually reduced by a hydrogen donating compound, leading to its change in color, from
deep violet to light yellow, which can be monitored spectrophotometrically [37]. The DPPH radical
scavenging activity results are as shown in Figure 1, while the IC50—the concentration of antioxidant
(extract/fractions) required for 50% scavenging of DPPH radicals—values are given in Table 3. From
the results, the ethyl acetate fraction had the highest activity, with an IC50 value of 0.078.
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Figure 1. 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging activity of extract and
fractions of M. longistyla. Data are expressed as mean ± standard deviation (SD; n = 3).
ME methanol extract; HF—hexane fraction; EF—ethyl acetate fraction; AF aqueous fraction;
DDM—2,6-di-tert-butyl-4-methylphenol.
Table 3. The concentration providing 50% inhibition (IC50) values of the different antioxidant assays.
Assays
IC50
ME HF EF AF Ascorbic Acid DDM
DPPH scavenging 0.090 0.363 0.079 0.089 0.006 0.050
NO scavenging 0.008 5.678 0.056 0.010 0.072 0.063
Fer reducing 0.051 0.087 0.078 0.009 0.053 0.003
ME—methanol extract; HF—hexane fraction; EF—ethyl acetate fraction; AF—aqueous fraction;
DDM—2,6-di-tert-butyl-4-methylphenol; DPPH—1,1-diphenyl-2-picryl-hydrazyl; NO—nitric oxide.
Nitric oxide is important in the regulation of several physiological processes, and several diseases
have been associated with a high concentration of NO [38]. The nitric oxide scavenging activity
can be determined by estimating for nitrate and nitrite, using the Greiss Illosvoy reaction [39]. At
a physiological pH (7.2), sodium nitroprusside decomposes in an aqueous solution to produce NO,
which reacts with oxygen to form stable products—nitrate and nitrite. Scavengers of NO compete with
oxygen, leading to a reduced production of nitrite ions [40].
Antioxidants 2019, 8, 400 7 of 15
In the nitric oxide scavenging assay, all of the extract and fractions exhibited a good scavenging
effect, with the methanol extract having the best scavenging effect (IC50 = 0.008), followed by an
aqueous fraction (IC50 = 0.010) and then the ethyl acetate fraction (IC50 = 0.056; Figure 2 and Table 3).
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Figure 2. Nitic oxide (NO) radical scavenging activity of the extract and fractions of M. longistyla. Data
are expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate
fraction; AF—aqueous fraction; DDM—2,6-di-tert-butyl-4-methylphenol.
Ferric reducing power is well linked with antioxidant activity [41], and compounds with a
reducing effect are usually electron donors that can reduce oxidized intermediates of lipid peroxidation
processes, thus acting as primary or secondary antioxidants [33]. In the ferric reducing antioxidant
assay, the methanol extract, aqueous fraction, and the ethyl acetate fraction had good reducing activity
(Figure 3), with IC50 values of 0.051, 0.009, and 0.078 respectively.
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Figure 3. Ferric reducing activity of the extract and fractions of M. longistyla. Data are expressed as mean
± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate fraction; AF—aqueous
fraction; DDM—2,6-di-tert-butyl-4-methylphenol.
On the whole, a better antioxidant activity was observed in the polar fractions, and this could be
because of the abundant presence of major secondary metabolites, such as tannins and flavonoids, in
these fractions, as supported by the higher TPC and TFC in these fractions. Phenolics are free-radical
terminators [33], thus having protective effects against many infectious and neuro degenerative diseases
such AD [42].
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The inhibition of cholinesterase enzymes is considered promising in the management of
neurological and neurodegenerative disorders such as AD, senile dementia, ataxia, and myasthenia
gravis, where a deficit in cholinergic neurotransmission is often observed [43,44]. Compounds with a
dual inhibitory effect on AChE and BuChE are also considered better, as BuChE also plays a minor role
in the regulation of AChE [45,46].
In this study, the methanol extract inhibited the acetylcholinesterase enzyme the most, followed
by the ethyl acetate and aqueous fractions, with respective percentage inhibitions of 81.629 ± 0.02,
76.985 ± 0.04, and 71.778 ± 0.01 (Figure 4). The hexane fraction had the least inhibitory action,
suggesting that the active constituents are likely to be polar. The study also suggests a better inhibition
of AChE as compared to BuChE, as both the crude extract and the various fractions had a lower
percentage inhibition and higher IC50 values in the later enzyme (Figure 5 and Table 4).
Antioxidants 2019, 8, x FOR PEER REVIEW 8 of 14 
inhibition of AChE as compared to BuChE, as both the crude extract and the various fractions had a 
lower percentage inhibition and higher IC50 values in the later enzyme (Figure 5 and Table 4). 
 
 
Figure 4. Acetylcholinesterase inhibitory activity of the extract and fractions of M. longistyla. Data are 
expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate 
fraction; AF—aqueous fraction. 
 
Figure 5. Butryrylcholinesterase inhibitory activity of the extract and fractions of M. longistyla. Data 
are expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate 
fraction; AF—aqueous fraction. 
Table 4. IC50 values for the cholinesterase inhibitory assay. AChE—acetylcholinesterase; BuChE—
butyrylcholinesterase. 
Assays IC50 
 ME HF EF AF Eserin Donepezil 
AChE 0.556 25.871 0.914 0.846 0.002 0.001 
BuChE 5.541 11.957 23.338 ND 0.002 0.001 
ND: Not determined. 
Figure 4. Acetylcholinesterase inhibitory activity of the extract and fractions of M. longistyla. Data
are expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate
fraction; AF—aqueous fraction.
Antioxidants 2019, 8, x FOR PEER REVIEW 8 of 14 
inhibition of AChE as compared to BuChE, as both the crude extract and the various fractions had a 
lower percentage inhibition and higher IC50 values in the later enzyme (Figure 5 and Table 4). 
 
 
Figure 4. Acetylcholinesterase inhibitory activity of the extract and fractions of M. longistyla. Data are 
expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate 
fraction; AF—aqueous fraction. 
 
Figure 5. Butryrylcholinesterase inhibitory activity of the extract and fractions of M. longistyla. Data 
are expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate 
fraction; AF—aqueous fraction. 
Table 4. IC50 values for the cholinesterase inhibitory assay. AChE—acetylcholinesterase; BuChE—
butyrylcholinesterase. 
Assays IC50 
 ME HF EF AF Eserin Donepezil 
AChE 0.556 25.871 0.914 0.846 0.002 0.001 
BuChE 5.541 11.957 23.338 ND 0.002 0.001 
ND: Not determined. 
Figure 5. Butryrylcholinesterase inhibitory activity of he extract and fractions of M. longistyla. Data
are expressed as mean ± SD (n = 3). ME—methanol extract; HF—hexane fraction; EF—ethyl acetate
fraction; AF—aqueous fraction.
Antioxidants 2019, 8, 400 9 of 15
Table 4. IC50 values for the cholinesterase inhibitory assay. AChE—acetylcholinesterase; BuChE—
butyrylcholinesterase.
Assays IC50
ME HF EF AF Eserin Donepezil
AChE 0.556 25.871 0.914 0.846 0.002 0.001
BuChE 5.541 11.957 23.338 ND 0.002 0.001
ND: Not determined.
The cholinesterase inhibitory activity of several medicinal plants has been reported in the
literature [47–51]. Also, antioxidants such as vitamin E and vitamin C have been reportedly associated
with a decrease in AD incidence and prevalence, [52] and AD patients on high doses of antioxidants
were reported to have a slower rate of cognitive deterioration [53]. Thus, the good antioxidant and
anticholinesterase activities of polar fractions in this study suggest that these fractions are good
sources of phenolic compounds, with potential cholinesterase inhibitory and antioxidant properties
that may find usefulness in the management of AD. This is the first report of such activities in
Macrosphyra longistyla.
We also correlated the phytochemical content with the observed activities of the plant. Several
pharmacological effects of the plant extract such, as being anti-inflammatory, antioxidant, and
antimicrobial, have also been associated with the presence of phenolic compounds [54,55], and r2
values have been used to show the relationship between the phytochemical constituents and activities
of medicinal plants [56]. There was a moderate correlation between the total phenolic content and the
DPPH and NO radical scavenging, as well as the AChE inhibitory activities (r2 = 0.439, 0.430, and
0.439, respectively). However, a better correlation was observed between the flavonoid content and
these activities (r2 = 0.695, 0.724, and 0.730, respectively), while the ferric reducing antioxidant power
correlated with the proautocyanidin content (r2 = 0.801; Table 5).
Table 5. Correlation of the total phenolic, total flavonoid, and proautocyanidin contents with antioxidant
and anticholinesterase activities.
Assays r
2 Values
Total Phenolics Total Flavonoids Proautocyanidin
DPPH scavenging 0.439 0.695 0.515
NO scavenging 0.430 0.724 0.558
Ferric reducing 0.012 0.276 0.801
AChE inhibition 0.439 0.730 0.557
BuChE inhibition 0.00154 0.131 0.325
Finally, the identification of possible compounds in the non-polar (hexane) fraction using GC-MS
revealed the presence of twenty-three compounds (Table 6). The most abundant was decanoic acid
methyl ester (24.303%), followed by 11,14-eicosadienoic acid methyl ester (16.788%), linoelaidic acid
(10.444%), pentadecanoic acid (9.300%), and 2-methyl-hexadecanal (9.285%).
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Table 6. Compounds identified through gas chromatography mass spectrometry (GCMS).
S/N Name of IdentifiedCompounds
Retention
Time (min)
%
Abundance
Molecular
Formula
Class of
Compound
Reported
Biological Effect References
1 2,6,8-trimethyl-decane 27.084 0.084 C13H28 Alkane Antifungal [57]
2 2-methyl-hexadecanal 30.833 9.285 C17H34O Aldehyde Antifungal [58]
3 Z,Z,Z-1,4,6,9-nonadecatetraene 34.147 0.349 C19H32 Alkene Antioxidant [59]
4 2-dodecanone 34.831 0.357 C12H24O
Aliphatic
ketones Nematocidal [60]
5 2-pentadecanone 35.591 1.630 C15H30O Ketone
Cytotoxic and
repellant [61,62]
6 17-octadecanal 39.211 0.119 C18H36O
Long-chain
aldehyde NR NR
7 Hexadecanoic acid 39.564 0.152 C16H32O2
Saturated fatty
acid
Anticancer and
anthelmintic [63,64]
8 2-methyl-dodecanoicacid 43.071 0.283 C11H22O2 Fatty acid Antimicrobial [65]
9 Neophytadiene 43.482 0.109 C20H38 Sesquiterpene Anti-inflammatory [66]
10 2-nonadecanone 43.611 1.942 C19H38O Alkanone Antimicrobial [67]
11 Decanoic acid methylester 46.414 24.303 C11H22O2
Fatty acid
ester Antimicrobial [68]
12 Phytol 47.053 0.202 C20H40O
Diterpene
alcohol
Antinociceptive,
antioxidant, and
anticholinesterase
[69,70]
13 Eicosanoic acid ethylester 48.585 5.265 C22H44O2 Fatty acid Anticancer [71]
14 Pentadecanoic acid 48.592 9.300 C15H30O2
Saturated fatty
acid Anthelmintic [64]
15
tetradecanoic
acid-12-methyl-methyl
ester
49.580 0.048 C16H32O2 Fatty acid
Anticancer and
antifungal [72,73]
16 11,14-eicosadienoic acidmethyl ester 51.562 16.788 C21H38O2 Fatty acid
Antioxidant and
anti-amylase [74]
17 8,11,14-ecosatrienoicacid 51.712 2.299 C20H34O2
Omega fatty
acid
Atopic dermatitis
and malignant
hypertension
[75,76]
18 Z-methyl-hexadec-11-enoate 51.963 4.204 C17H32O2
Fatty acid
methyl ester Antimicrobial [77]
19
Dodecanoic
acid-10-methyl-methyl
ester
52.643 1.957 C14H28O2
Fatty acid
methyl ester Anticoagulant [78]
20 Linoelaidic acid 53.559 10.444 C18H32O2
Omega-6 trans
fatty acid
Anticholinesterase,
anti-mycobacterium,
anticancer, and
antioxidant
[79–82]
21 Z,E-3,13-octadecadien-1-ol 53.763 2.707 C18H34O Fatty alcohol Antimicrobial [83]
22 (Z)-methyl-Heptadec-9-enoate 53.953 0.179 C18H34O2 Fatty acid Antibiotic [84]
23
Hexadecanoic
acid-2-methyl-methyl
ester
54.615 1.139 C18H36O2
Fatty acid
methyl esters
Antimicrobial and
antioxidant [85]
NR: Not reported. The various identified compounds have been reported to have different biological effects, such
as being antimicrobial, antioxidant, anticoagulant, anticholinesterase, anticancer, and anthelmintic. All of these
ultimately contribute to the overall activity of the plant.
4. Conclusions
This study revealed the antioxidant and anticholinesterase activities of the compounds present
in M. longistyla, and suggest the potential use of extracts from this plant for the management of
neurodegenerative conditions. The polar fractions had the highest antioxidants and anticholinesterase
constituents, which can be further exploited. Also, the GCMS analysis identified the compounds likely
to contribute to the observed activities.
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